Medicine recall 6 March 2014

Viread 245 mg film-coated tablets – possible presence of silicone rubber

Yes – this has been recalled
The problem
(Gilead Sciences Limited) Pharmacists should quarantine any remaining stocks affected batches and return them to the original wholesaler for credi - class 2 action within 48 hours. (EL (14)A/03)
What to do
Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA) Official notice ↗

06 March 2014

Class 2 medicines recall

Action within 48 hours

Pharmacy, dispensing clinic and wholesale level recall

MDR 07-03/14

Product details

Gilead Sciences Limited

Viread 245 mg Film-Coated Tablets

(Tenofovir disoproxil fumarate)

EU/1/01/200/001-002

Alert details

  • Batch number: KFBSD
    • Expiry date: December 2017
    • Pack size: 30 film-coated tablets
    • First distributed: 31 January 2014
  • Batch number: KFBTD
    • Expiry date: December 2017
    • Pack size: 30 film-coated tablets
    • First distributed: 16 October 2013

Gilead Sciences Limited is recalling the above batches of Viread 245 mg Film-Coated Tablets due to the possible presence of silicone rubber. A failure of equipment used in the manufacture of the active pharmaceutical ingredient formulated in these medicinal product batches may have resulted in damage to silicone gaskets and silicone fragments entering the product in these recalled lots. 

Pharmacists are asked to quarantine any remaining stocks of the above batches and return them to the original wholesaler for credit. For stock enquiries please contact Gilead Sciences Customer Services on 01223 897400.

For medical information enquires please contact Gilead Sciences Ltd Medical Information at 01223 897555 or by email to ukmedinfo@gilead.com.

Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.

Download documents

Updated 6 March 2014. This page summarises an official notice. Details can change – always follow the official notice.

Website built by: www.NocturnalMedia.co.uk